Drug Effect Clinical Trial
Official title:
A Pilot Study for Optimizing Meropenem Administration in the Intensive Care Unit - Short Six Times vs Prolonged Three Times Courses Daily
Can antibiotic drugs be administered faster and make acceptable serum concentrations if we give short but multiple infusions compared to long and fewer infusions? In this study we will compare giving meropenem 1 gram 6 times daily in 15 minutes infusions to the recommended 2 gram 3 times daily in 3 hours infusions. In patients in the intensive care unit, the need for intravenous access is of essence. If 6 short infusions results in the same serum concentrations as 3 long infusions, we will increase intravenous access from 15 to 22.5 hours daily.
The primary aim of this pilot study is to examine if the dosing of the antibiotic meropenem given as 1 gram 6 times daily in 15 minutes infusions can be compared to 2 grams given 3 times daily in 3 hours infusion when measuring the serum concentration above the minimum inhibitory concentration (MIC) ≥ 50 % of the time (2 mg/l). The secondary aims are - That both administration forms will result in serum concentrations above MIC ≥ 100 % of the time (2 mg/l) - Days in hospital - 30 days mortality after admittance to the ICU - Serious side-effects Five extra blood samples will be performed 24, 48 and 72 hours between two dosing intervals. The dose will be adjusted according to renal function which will be monitored daily. The patients will be supervised for adverse effects until 2 days after treatment has stopped. The study will be performed from 2021 to the end of 2024. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04235894 -
An Observer Rating Scale of Facial Expression Can Predict Dreaming in Propofol Anesthesia
|
||
| Completed |
NCT04166890 -
Comparison of the Efficacy and Safety of Two Homologous Active Principles for Local Dental Anesthesia
|
Phase 4 | |
| Completed |
NCT03265613 -
Safety and Efficacy of Expanded Allogeneic AD-MSCs in Patients With Moderate to Severe Psoriasis
|
Phase 1/Phase 2 | |
| Recruiting |
NCT04037774 -
Comparision of Different Doses of Dexmedetomidine With Low Dose Bupivacaine in Selective Spinal Anesthesia.
|
Phase 4 | |
| Recruiting |
NCT05113420 -
The Efficacy and Safety of Different Phlebotonic Drugs in Children With Venous Malformations
|
||
| Completed |
NCT03801629 -
Neuroimmune Effects of Opioid Administration
|
Phase 1 | |
| Completed |
NCT04052776 -
Acute Effects of Pharmacological Neuromodulation on Leg Motor Activity in Patients With SCI Treated With EES
|
Phase 1 | |
| Completed |
NCT04037085 -
Ketamine to Improve Recovery After Cesarean Delivery - Part 1
|
Phase 2 | |
| Completed |
NCT05050071 -
Evaluation of Antibacterial Effect of Allium Sativum, Calcium Hydroxide and Their Combination in Infected Mature Teeth
|
Phase 2/Phase 3 | |
| Completed |
NCT03305666 -
Trial of Injected Liposomal Bupivacaine vs Bupivacaine Infusion After Surgical Stabilization of Rib Fractures
|
Phase 4 | |
| Completed |
NCT06238154 -
Flurbiprofen Tablet vs Spray In Oral Soft Tissue Wounds
|
Phase 4 | |
| Not yet recruiting |
NCT04392427 -
New Antiviral Drugs for Treatment of COVID-19
|
Phase 3 | |
| Recruiting |
NCT05300152 -
Pulpotomy Medications in Primary Teeth
|
N/A | |
| Recruiting |
NCT04594889 -
Comparison of Sirolimus vs Paclitaxel Drug Eluting Balloon for Below-the-knee Angioplasty in Critical Limb Ischemia
|
N/A | |
| Not yet recruiting |
NCT05018936 -
Efficacy and Safety of Hetrombopag in Non-severe Aplastic Anemia
|
Phase 2/Phase 3 | |
| Completed |
NCT04245774 -
Comparing the Effects of Levobupivacaine and Bupivacaine in Saddle Spinal Anesthesia
|
Phase 4 | |
| Completed |
NCT04449536 -
Cysteine-lowering Treatment With Mesna
|
Phase 1 | |
| Recruiting |
NCT05975255 -
Dose Finding Study for Remimazolam in Children
|
Phase 2 | |
| Active, not recruiting |
NCT04254731 -
Effects of Switching From Racemic Methadone to R-methadone on QTc Intervals
|
Phase 4 | |
| Completed |
NCT03635684 -
Evaluation of Efficacy and Safety of Subcutaneous Acetaminophen
|
Phase 2 |